Northwest Biotherapeutics to Ring the NASDAQ Stock Market Opening Bell

Published: Dec 17, 2012

ADVISORY, Dec. 17, 2012 (GLOBE NEWSWIRE) -- What: Northwest Biotherapeutics, Inc. [NWBO], a biotechnology company focused on developing immunotherapy products to treat cancers more effectively and without toxicity, now in Phase III clinical trials, will visit the NASDAQ MarketSite in Times Square.

Back to news